BEVERLY, Mass., Aug. 17, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. (LXXGF), (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative ...
SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode, a leader in molecular diagnostics panel testing, is excited to announce a significant enhancement to its BioCode ® Gastrointestinal Pathogen ...
Germantown, Maryland, and Venlo, the Netherlands, June 03, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAstat-Dx Gastrointestinal ...
Join us for a compelling webinar that delves into gastrointestinal pathogen diagnostics and the crucial role of targeted testing options in routine patient care. A Microbiology and Virology Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results